ERGANEO

Erganeo

#Financial #More

ERGANEO

Status:
Active


Investments List

Date Company Article Money raised
2019-09-12 Ermium Therapeutics Erganeo investment in Series A - Ermium Therapeutics 6.3 M EUR

More informations about "Erganeo"

About us - ERGANEO

Erganeo is a French transfert company, specialising in disruptive innovations (Deep Tech) with a strong societal impact. We invest as soon as possible to secure Researchers new inventions, …See details»

Erganeo - Crunchbase Investor Profile & Investments

Erganeo is a research firm that specializes in investing in companies at various stages, including seed-stage, early-stage, and later-stage businesses. The firm focuses its investments on a …See details»

Exclusive license agreement secured with Erganeo for EVerGel, …

Mar 5, 2024 EVerZom participated in the 19th ECCO (European Crohn's and Colitis Organization) Congress, held in Stockholm in February 2024, and presented its advances to …See details»

ERGANEO | ERGANEO

The French government has allocated €275 million to 17 "maturation - prematuration" consortia including 9 in which Erganeo participates. NEWS #ERGANEO. 01/03/2023 Erganeo wishes …See details»

The SATT IDF Innov is changing with the times... and is now Erganeo

IDF Innov is reinventing itself and changing with the times to become Erganeo, on a mission to invent a better world. Erganeo is an investment fund that specializes in breakthrough …See details»

Our team | ERGANEO

Erganeo and all the teams involved in this project are defending a utopia: bringing scientific innovation to the economic world so that the industry of tomorrow can be at the service of Humans. Jobs; Contact us; 01 44 23 21 50; My space. …See details»

Erganeo - Investments, Portfolio & Company Exits - Crunchbase

Erganeo has invested in Ermium Therapeutics on Sep 12, 2019. This investment - Series A - Ermium Therapeutics - was valued at . obfuscated. obfuscated. How many investments has …See details»

Erganeo | Emakina

Erganeo is a French technology transfer company specialising in breakthrough innovations that have a strong impact on society. Since its inception in 2012, it has invested more than €42 million in projects with far-reaching impact. Its …See details»

Erganeo - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Erganeo uses 9 technology products and services including HTML5, Apache Server, and Office 365, according to G2 Stack. Erganeo is actively using 8 technologies for its website, according …See details»

Gene and cell therapy by suicide gene to treat liver cancer

Jan 5, 2023 An exclusive license was signed on 10 November, 2022, between Erganeo and the start-up Persea, for development of a new treatment for liver cancer. It is a cell therapy via …See details»

Erganeo investment portfolio - PitchBook

Erganeo has made numerous investments in companies like Ermium Therapeutics, Neurallys, and Orixha within the Drug Discovery, Surgical Devices, and Monitoring Equipment industries. …See details»

Erganeo is committed to the future with the European Sustainable ...

This European Week is an initiative whose objective is to facilitate the organization of activities that promote sustainable development and to make these contributions visible on a common …See details»

Erganeo - Updates, News, Events, Signals & Triggers - Crunchbase

Erganeo is a venture capital firm that specializes in investing in companies at various stages.See details»

Erganeo Information - RocketReach

The NAICS codes for Erganeo are [52, 523]. What is the SIC code for Erganeo? The SIC codes for Erganeo are [67, 679, 6799]. Top Erganeo Employees Naceur Tounekti Président Exécutif …See details»

STARTUP - ERGANEO

Erganeo helps launch start-up Ermium Therapeutics, which has already raised €6.3m in start-up capital. SUCCESS #STARTUP. 08/23/2019 i-Lab Award 2019: Four winning start-ups backed …See details»

Erganeo - Crunchbase

Erganeo is a venture capital firm that specializes in investing in companies at various stages.See details»

EVerZom: Therapeutic ambitions in exosome-based biotherapies

Mar 5, 2024 EVerZom, a spin-off of CNRS/Université Paris Cité specializing in exosomes, announces the signing of a second exclusive licensing agreement with Erganeo for the …See details»

Technologies - ERGANEO

Research is one of the building blocks of societal progress. It shapes a playground in which commitment and investment must participate in global and virtuous evolution for the greatest …See details»

News | ERGANEO

Nov 27, 2024 Erganeo signs a licensing agreement with start-up EverZom, creating a platform for the production of biological tools, extracellular vesicles, to benefit the emergence of …See details»